TipRanks
Quoin Pharmaceuticals (DE:2EB0)
FRANKFURT:2EB0
Germany Market
2EB0
Quoin Pharmaceuticals
RESEARCH TOOLSreports

Quoin Pharmaceuticals (2EB0) Stock News & Sentiment

0 Followers
Quoin Pharmaceuticals Gains FDA Rare Pediatric Designation
Premium
Company Announcements
Quoin Pharmaceuticals Gains FDA Rare Pediatric Designation
9d ago
8K
QNRX
Quoin Reports Positive Interim QRX003 Netherton Data
Premium
Company Announcements
Quoin Reports Positive Interim QRX003 Netherton Data
23d ago
8K
QNRX
Quoin Pharmaceuticals Shareholders Approve Governance and Compensation Changes
Premium
Company Announcements
Quoin Pharmaceuticals Shareholders Approve Governance and Compensation Changes
1M ago
8K
QNRX
QNRX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
QNRX Upcoming Earnings Report: What to Expect?
1M ago
QNRX
Naz Rahman Maintains Buy on Quoin as QYLEKI Progress Offsets Financing Risks, While Cutting 12-Month Price Target from $40 to $16
Premium
Ratings
Naz Rahman Maintains Buy on Quoin as QYLEKI Progress Offsets Financing Risks, While Cutting 12-Month Price Target from $40 to $16
3M ago
QNRX
Quoin Advances QYLEKI Toward First Netherton Therapy
Premium
Company Announcements
Quoin Advances QYLEKI Toward First Netherton Therapy
3M ago
8K
QNRX
Quoin Wins Japan Orphan Drug Status for QRX003
Premium
Company Announcements
Quoin Wins Japan Orphan Drug Status for QRX003
4M ago
8K
QNRX
More DE:2EB0 News >

2EB0 News on the Web

Quoin Pharmaceuticals registers to sell 9.37M ADRs for holders
TipRanks News
Bullish
Quoin Pharmaceuticals Gains FDA Rare Pediatric Designation
TipRanks News
Neutral
Quoin Reports Positive Interim QRX003 Netherton Data
TipRanks News
Neutral
Quoin Pharmaceuticals (QNRX) Raises $50M, Shares Surge 38% Premarket Amid Growth Prospects
GuruFocus News
Bullish
Quoin Pharmaceuticals (QNRX) Surges 38.5% Premarket Amid Growth Speculation Despite Unprofitability
GuruFocus News
Bullish
Maxim Group Remains a Buy on Quoin Pharmaceuticals (QNRX)
TipRanks News
Bullish
Naz Rahman Maintains Buy on Quoin as QYLEKI Progress Offsets Financing Risks, While Cutting 12-Month Price Target from $40 to $16
TipRanks News
Bullish
Quoin Advances QYLEKI Toward First Netherton Therapy
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
DE:2EB0
Sector Average
Media Buzz
This Week1 articles
Weekly Average2.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:2EB0’s Media Buzz Sentiment?
1 articles about DE:2EB0 were published this week. In an average week, 2.75 articles are published.
    What is DE:2EB0’s weekly average amount of articles?
    In an average week, 2.75 articles about DE:2EB0 are published.
      What is DE:2EB0’s News Sentiment?
      100% of articles about DE:2EB0 were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        CRLCharles River Labs
        DFTXDefinium Therapeutics
        AMRXAmneal Pharmaceuticals
        SMMTSummit Therapeutics
        ABEOAbeona Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week